Drew Moghanaki/X
Mar 31, 2025, 12:26
Drew Moghanaki: Selective SBRT can help patients with metastatic EGFR+ NSCLC get more MILEAGE out of every one of these drugs
Drew Moghanaki, Co-Chair at U.S. Department of Veterans Affairs, shared on LinkedIn:
“Selective SBRT can help patients with metastatic EGFR+ NSCLC get more MILEAGE out of every one of these drugs. Ask a radiation oncologist to learn more.”
Jim Baranski, Executive Director at Lung Cancer Foundation of America, shared Drew Moghanaki’s post on LinkedIn:
“Heads up NSCLC lung cancer patients… check this out and ask your doctor!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53